David Alan Campbell - Net Worth and Insider Trading
David Alan Campbell Net Worth
The estimated net worth of David Alan Campbell is at least $16 Million dollars as of 2024-11-05. David Alan Campbell is the President and CEO of Janux Therapeutics Inc and owns about 282,054 shares of Janux Therapeutics Inc (JANX) stock worth over $16 Million. Details can be seen in David Alan Campbell's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Alan Campbell has not made any transactions after 2024-10-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Alan Campbell
David Alan Campbell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Alan Campbell owns 1 companies in total, including Janux Therapeutics Inc (JANX) .
Click here to see the complete history of David Alan Campbell’s form 4 insider trades.
Insider Ownership Summary of David Alan Campbell
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| JANX | Janux Therapeutics Inc | 2024-10-28 | director & Chief Executive Officer |
David Alan Campbell Latest Holdings Summary
David Alan Campbell currently owns a total of 1 stock. David Alan Campbell owns 282,054 shares of Janux Therapeutics Inc (JANX) as of October 28, 2024, with a value of $16 Million.
Latest Holdings of David Alan Campbell
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| JANX | Janux Therapeutics Inc | 2024-10-28 | 282,054 | 54.97 | 15,504,508 |
Holding Weightings of David Alan Campbell
David Alan Campbell Form 4 Trading Tracker
According to the SEC Form 4 filings, David Alan Campbell has made a total of 2 transactions in Janux Therapeutics Inc (JANX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Janux Therapeutics Inc is the sale of 25,000 shares on October 28, 2024, which brought David Alan Campbell around $1 Million.
Insider Trading History of David Alan Campbell
- 1
David Alan Campbell Trading Performance
David Alan Campbell Ownership Network
Ownership Network List of David Alan Campbell
Ownership Network Relation of David Alan Campbell
David Alan Campbell Owned Company Details
What does Janux Therapeutics Inc do?
Who are the key executives at Janux Therapeutics Inc?
David Alan Campbell is the director & Chief Executive Officer of Janux Therapeutics Inc. Other key executives at Janux Therapeutics Inc include director & 10 percent owner Ra Capital Healthcare Fund Lp , 10 percent owner Avalon Ventures Xi, L.p. , and Chief Business Officer Andrew Hollman Meyer .
Janux Therapeutics Inc (JANX) Insider Trades Summary
Over the past 18 months, David Alan Campbell made 2 insider transaction in Janux Therapeutics Inc (JANX) with a net sale of 50,000. Other recent insider transactions involving Janux Therapeutics Inc (JANX) include a net sale of 3,324,326 shares made by Avalon Ventures Xi, L.p. , a net sale of 653,961 shares made by Jay Lichter , and a net purchase of 1,695,008 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 2,782,995 shares of Janux Therapeutics Inc (JANX) in total and bought 1,200,000 shares, with a net sale of 1,582,995 shares. During the past 18 months, 6,605,716 shares of Janux Therapeutics Inc (JANX) were sold and 4,244,570 shares were bought by its insiders, resulting in a net sale of 2,361,146 shares.
Janux Therapeutics Inc (JANX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Janux Therapeutics Inc Insider Transactions
David Alan Campbell Mailing Address
Above is the net worth, insider trading, and ownership report for David Alan Campbell. You might contact David Alan Campbell via mailing address: C/o Janux Therapeutics, Inc., 11099 N. Torrey Pines Road, Suite 290, La Jolla Ca 92037.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
